These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Tüter G; Kurtiş B; Serdar M J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249 [TBL] [Abstract][Full Text] [Related]
5. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients. Alpagot T; Konopka K; Bhattacharyya M; Gebremedhin S; Düzgüneş N J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients. Alpagot T; Remien J; Bhattacharyya M; Konopka K; Lundergan W; Duzguneş N Arch Oral Biol; 2007 Nov; 52(11):1102-8. PubMed ID: 17586460 [TBL] [Abstract][Full Text] [Related]
7. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1. Tüter G; Kurtiş B; Serdar M; Yücel A; Ayhan E; Karaduman B; Ozcan G J Clin Periodontol; 2005 Sep; 32(9):1011-5. PubMed ID: 16104967 [TBL] [Abstract][Full Text] [Related]
8. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789 [TBL] [Abstract][Full Text] [Related]
9. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. Mäntylä P; Stenman M; Kinane D; Salo T; Suomalainen K; Tikanoja S; Sorsa T J Periodontal Res; 2006 Dec; 41(6):503-12. PubMed ID: 17076774 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for periodontitis in HIV patients. Alpagot T; Duzgunes N; Wolff LF; Lee A J Periodontal Res; 2004 Jun; 39(3):149-57. PubMed ID: 15102043 [TBL] [Abstract][Full Text] [Related]
11. Assessment of aprotinin influence on periodontal clinical status and matrix metalloproteinases 1, 2 and their tissue inhibitors saliva concentrations in patients with chronic periodontitis. Pietruska M; Pietruski J; Skurska A; Bernaczyk A; Zak J; Zelazowska B; Dolińska E; Paniczko-Drezek A; Wysocka J Adv Med Sci; 2009; 54(2):239-46. PubMed ID: 19758971 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in peri-implant sulcular fluid]. Lu SH; Liang X; Xie ZG; Zhang JY; Xu L; Sun HQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):274-6. PubMed ID: 15071939 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. Pozo P; Valenzuela MA; Melej C; Zaldívar M; Puente J; Martínez B; Gamonal J J Periodontal Res; 2005 Jun; 40(3):199-207. PubMed ID: 15853964 [TBL] [Abstract][Full Text] [Related]
14. MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis. Ertugrul AS; Dursun R; Dundar N; Avunduk MC; Hakki SS Arch Oral Biol; 2013 Jul; 58(7):843-52. PubMed ID: 23433942 [TBL] [Abstract][Full Text] [Related]
15. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. Hernández Ríos M; Sorsa T; Obregón F; Tervahartiala T; Valenzuela MA; Pozo P; Dutzan N; Lesaffre E; Molas M; Gamonal J J Clin Periodontol; 2009 Dec; 36(12):1011-7. PubMed ID: 19929954 [TBL] [Abstract][Full Text] [Related]
16. Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease. Biyikoğlu B; Buduneli N; Kardeşler L; Aksu K; Pitkala M; Sorsa T J Periodontol; 2009 Aug; 80(8):1307-14. PubMed ID: 19656031 [TBL] [Abstract][Full Text] [Related]
17. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107 [TBL] [Abstract][Full Text] [Related]
18. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. Figueredo CM; Areas A; Miranda LA; Fischer RG; Gustafsson A J Clin Periodontol; 2004 Aug; 31(8):615-9. PubMed ID: 15257737 [TBL] [Abstract][Full Text] [Related]
19. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. Erdemir EO; Duran I; Haliloglu S J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease. Passoja A; Ylipalosaari M; Tervonen T; Raunio T; Knuuttila M J Clin Periodontol; 2008 Dec; 35(12):1027-31. PubMed ID: 19040578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]